Dorian Therapeutics is developing senomorphic or senoblocking compounds aimed at restoring tissue regenerative capacity.
×
Dorian Therapeutics � senoblockers
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD